115 PaidiR
Candidates for the weight loss program through Klinic in Provo typically have a BMI of 30 or above, or 27 alongside a specific weight-related health condition
According to our data and published data on other medications, we can indirectly infer that oral semaglutide at a dose of 14 mg is associated with less weight loss and a smaller reduction in BMI compared to tirzepatide at all maintenance doses, subcutaneous semaglutide at 2.4 mg weekly, and oral semaglutide at 50 mg daily
Commercial involvement does not invalidate the data, but it is relevant when assessing independence and the need for replication
1-3 4 (Glutathione in dermatology: A bright future or fading hype?, CosmoDerma, 2025)
FDA-Approved Weight Loss Medications Available Near You Klinic specializes in prescribing branded, FDA-approved weight loss medications such as Wegovy, Oral Wegovy, Zepbound, and Foundayo, available at our clinics in Kirkland, Washington